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Background: The pathogenesis of infection with Burkholderia cepacia complex (Bcc) organisms may be linked to its capacity to invade
respiratory epithelium.
Methods: An antibiotic exclusion assay was used to study B. dolosa AU4459 and B. cenocepacia J2315 invasion into wild-type (WT) and CFTR-
deficient respiratory epithelial cells. Inhibitors were used to evaluate Bcc invasion dependency on hostmicrotubule (mt) andmicrofilament (mf) systems.
Results: B. dolosa entered WT-CFTR cells with 5-fold greater efficiency than CFTR deficient cells (25% vs 5%, respectively). Invasion dropped
to b0.5% after either mf or mt inhibition. B. cenocepacia entered WT (0.05%) and CFTR-deficient cells (0.07%) with similarly low efficiencies,
which significantly decreased with either mf or mt inhibition (0.008% and 0.002%, respectively).
Conclusion: B. dolosa and B. cenocepacia enter respiratory epithelial cells in a mf and mt dependent fashion. Mutated CFTR leads to less
internalization of B. dolosa, but not B. cenocepacia.
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Burkholderia cepacia complex (Bcc) organisms have been
recognized as opportunistic pathogens in cystic fibrosis (CF)
since the 1980s and infection prevalence now approaches 30% in
some CF centers [2]. Approximately 20% of Bcc colonized
patients develop a rapidly progressive necrotizing pneumonia
(cepacia syndrome) [10,12]. However, other patients exhibit
transient colonization or indolent disease illustrating the variabil-
ity in interaction of bacterial and host factors that contribute to
disease [11,15,17,19]. Part of this variability is due to differences
in the organisms themselves. Fifteen genetically distinct geno-
movars have been identified with over 43 species in the genus⁎ Corresponding author. Department of Pediatrics, University of Texas
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doi:10.1016/j.jcf.2009.10.002Burkholderia [5,12,19,26,29]. Burkholderia dolosa (genomovar
VI) [27] accounts for only 3% of USBcc strains [10]; however, in
one treatment center, the prevalence of B. dolosa infection was
greater than 10-fold above the national average due to infection
with an epidemic strain designated SLC-6 [10]. Among Bcc
organisms, B. dolosa appears to be the most antibiotic resistant
[17,28]. Apart from clinical observations, virtually nothing is
known about the pathogenesis of infection with B. dolosa in
comparison to a more widely studied species, B. cenocepacia,
which accounts for the majority of Bcc infections in the United
States CF population [8,11,13,14]. In particular, the pathogenesis
of B. dolosa infection may involve invasion into respiratory
epithelial cells.
Mechanisms of host cell invasion have been studied
extensively in gram negative enteric pathogens and all involve
rearrangement of host cell cytoskeletal components [6,9,25].
Actin andmicrotubule polymerizationmay be required for uptake
of intestinal pathogens [1,6]. Among respiratory pathogens,d by Elsevier B.V. All rights reserved.
Table 1
Susceptibility of clinical SLC6 isolates to killing by a triple antibiotic combination
of meropenem, ceftazidime and amikacin.
SLC6
isolate
Initial
inoculum×106CFU
Recovered
inoculum×102CFU
Killing
efficiency (%)
AU4459 6 1 99.9983
AU5404 5 3 99.9940
AU4894 4 9 99.9775
AU4750 12 30 99.9750
AU3123 6 30 99.9500
AU4881 7 60 99.9143
AU3556 10 200 99.8000
AU4298 7 500 99.2857
AU9248 5 1000 98.0000
Each antibiotic concentration was 1 mg/mL and bacteria were exposed for 3 h
at 37°C.
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microfilament-, but not microtubule-dependent fashion after
binding to the cystic fibrosis transmembrane conductance
regulator protein, CFTR [3,20]. CFTR defects impair the entry
and subsequent clearance of PA, suggesting that CFTR-
dependent cell entry functions in host cell defense [3,20,24].
Certain Bcc organisms invade host epithelial cells in an actin-
dependent fashion [2,9,10], but few studies have examined the
role that CFTR may play in Bcc invasion [5,10,22,23]. In the
present study, the role that CFTR, microtubules and microfila-
ments play in the invasion of B. dolosa and B. cenocepacia into
respiratory epithelial cells is examined.
2. Materials and methods
2.1. Bacterial strains and growth conditions
B. dolosa clinical isolates (strain designated SLC6) were
examined for antibiotic susceptibility. The most sensitive
isolate AU4459 was further studied in invasion assays. The
B. cenocepacia clinical isolate J2315 (strain designated ET12)
was studied. The PA studied was a laboratory strain designated
PAO1-V (provided by the Dr. G. Pier laboratory, Harvard
University, Boston, MA). The Burkholderia isolates were
grown overnight on blood agar plates and PAO1 was grown on
tryptic soy agar plates (TSA), followed by inoculation in LB for
growth to mid-log phase, which was monitored by following the
optical density at 650 nm (OD650) on a Genesys 20 spectro-
photometer (ThermoSpectronic).
2.2. Cell culture
CFT1 cells are respiratory epithelial cells derived from a
ΔF508 homozygous patient and immortalized with the human
papilloma virus 18 E6 and E7 genes [30]. They were
complemented with either a full-length wild type (WT)-CFTR
gene introduced by a retrovirus and designated CFT1-LCFSN,
or with the control gene encoding β-galactosidase, CFT1-LC3
(cells provided by Dr. J. Yankaskas, University of North
Carolina, Chapel Hill). CFT1 cells were grown in Ham's F12
medium supplemented with 10 μg/mL insulin, 1 mM hydro-
cortisone, 3.75 μg/mL endothelial cell growth supplement,
25 ng/mL epidermal growth factor, 30 nM triiodo-L-thyronine,
5 μg/mL transferrin, and 10 ng/mL cholera toxin (CF12 media).
Selection for transfected cells was provided through addition of
neomycin at 150 μg/mL, which was removed by washing the
plates with phosphate-buffered saline (PBS) and replaced with
neomycin-free CF12 media immediately prior to the invasion
experiments with bacteria [30]. 16HBE cells were isolated from
an individual with two WT copies of the CFTR gene and
immortalized using the simian virus-40 (provided by Dr. D.
Gruenert, University of California, San Francisco, California),
and grown using standard techniques [7]. All cultured cell lines
were serum-starved for 10 min before infection with bacteria.
All reagents for media supplementation were obtained from
Sigma Aldrich (St. Louis) unless indicated. To assess whether
B. dolosa or B. cenocepacia exposure induced apoptosis andhence, loss of respiratory epithelial cells, confluent cultures of
LCFSN and LC3 cells in 6 well plates were inoculated with
bacteria and incubated for 1, 2, and 3 h [3]. The cells were then
stained with FITC-labeled M30 antibody, which is a monoclo-
nal antibody to a cytokeratin 18 cleavage product generated by
caspase 6 activity during apoptosis. The M30 stained cells were
evaluated by flow cytometry (FACS Calibur, BD Biosciences).2.3. Antibiotic susceptibility assay
To enumerate live intracellular bacteria, target cells are
incubated with bacteria followed, typically, by gentamicin to
kill the extracellular bacteria, then washed, lysed and plated
[2]. Because Bcc organisms are resistant to numerous drugs
including gentamicin, the susceptibility of several clinical
isolates of the SLC6 strain of B. dolosa were tested with both
double and triple combinations of other antibiotics to determine
an antibiotic combination useful for a modified assay (Table 1).
The combination of meropenem (NovaPlus produced for
Astra Zeneca: stock 50 mg/mL), ceftazidime (SanDoz GMBH
produced for NovaPlus: stock 100 mg/mL) and either amikacin
(Sicor Pharmaceuticals Inc: stock 250 mg/mL) or tobramycin
(Abraxis Pharmaceutical produced for Novaplus: stock 40 mg/
mL) provided the highest killing efficiency of B. dolosa
AU4459. A bacterial inoculum of 5–10×106 organisms was
used. A killing efficiency, defined as ((initial inoculum−
recovered inoculum)/initial inoculum)×100%, greater than
99.99% (N4 log killing of an initial inoculum of 106CFU)
was deemed adequate to proceed with the invasion studies [2].
To mimic the conditions of the invasion assay, aliquots of
meropenem, ceftazidime, amikacin and tobramycin were
diluted in CF12 media without neomycin to create four separate
1 mg/mL antibiotic stocks, as well as 1:10, 1:100 and 1:1000
dilutions of each antibiotic. First, single antibiotic concentra-
tions of 1 mg/mL were tested to determine their killing
efficiency. Bacteria were removed from fresh overnight plates
and grown in LB at 37 °C in a shaking incubator until the
bacteria reached an OD650 of 0.4. After incubation in a cell
culture incubator for 1 h, the wells were serially diluted and
plated on blood agar, incubated overnight, and counted.
Fig. 1. B. dolosa enters respiratory epithelial cells. A. Transmission electron
micrograph (TEM) depicting entry of a clinical strain of B. dolosa bacterium
into a CFT1-LCFSN, WT-CFTR expressing, respiratory epithelial cell. Note the
alignment of the bacterium with a membrane protrusion which suggests
microtubule and microfilament involvement. Scale bar indicates 1 µm. B. TEM
depicting intracellular perinuclear vacuoles, which have been associated with
microtubular trafficking, containing a clinical strain of B. dolosa in a CFT1-
LCFSN cell. Both images were obtained after 6 hours of incubation with
bacteria at an MOI of 15. Scale bar=4 µm.
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A 96-well plate was seeded with CFT1-LC3, CFT1-LCFSN
or 16HBE cells (105 cells per well). Once confluent (~24 h), the
growth media was removed, the wells were washed with PBS
and the neomycin-free media was added to the wells. Stocks of
cytochalasin D (2 mM in DMSO; Sigma) and colchicine
(10 mM in sterile water; Sigma) were stored in the dark at
4°C. Final concentrations of cytochalasin D and colchicine in
neomycin-free CF12 were 2 and 10 µM, respectively (~1 µg/
mL cytochalasin D and ~4 µg/mL colchicine). Cytochalasin D,
colchicine or neomycin-free CF12 media was added to the wells
and the plates were incubated for 1 h prior to a PBS wash
followed by addition of bacteria (multiplicity of infection [MOI]
confirmed by plating serial dilutions). The bacteria were
approximated to the epithelial cells by centrifugation of the
plates (5 min at ~330× g) and then incubated at 37 °C for 1 h to
allow for invasion. The wells were washed ×3 with PBS to
remove extracellular bacteria and the antibiotic-free media
replaced with media supplemented with 1 mg/mL each of
meropenem, ceftazidime and amikacin to kill adherent
extracellular bacteria. The cells were then incubated for 3 h at
37 °C, washed with PBS, and lysed (40 mM Tris–Cl pH 7.4,
2 mM EGTA, 0.1% Triton ×100) to release the intracellular
bacteria. Bacteria were quantified by serial dilution. The %
invasion efficiency was calculated as (recovered organisms/
inoculated organisms)/epithelial cell number×100%. All
experiments were run in triplicate.
2.5. Transmission electron microscopy (TEM)
Cells were washed with PBS, the media replaced with
neomycin-free media and inoculated with B. dolosa (AU4459)
at an MOI between 15 and 20 in three separate experiments. The
cells were incubated with bacteria for 2, 4 and 6 h, washed with
PBS, fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate
for one hour at 4 °C, washed again, then incubated with 1.25%
osmium tetroxide in PBS for 90 min at 25 °C. Samples were
fixed in 4% uranyl acetate, thin-sectioned (90 nm) in Polybed
812 (Polysciences, Warrington, PA), post-stained in uranyl
acetate and lead citrate, and then visualized using a Zeiss 902
microscope (Zeiss, Thornwood, NY).
2.6. Quantitative adherence assay
CFT1-LCFSN or CFT1-LC3 cells (106 cells per well) were
seeded onto round coverslips within 24-well tissue culture plates
(Corning) then grown to confluence. Overnight cultures of B.
dolosa grown on blood agar plates were diluted into LB to an
OD650 of 0.2 and then grown in a shaking incubator at 37 °C to
OD650 of 0.8. The bacteria were plated to determine theMOI. The
epithelial cells were washed twice with 500 µL PBS per well. An
aliquot of 300 µL CF12 neomycin-free media and 8 µL of
bacteria were added to each well. The plates were centrifuged
(5 min, ~330× g, 21 °C) and incubated for 25min (37 °C, 5%
CO2, humidified air). Eachwell was washed ×4with 500 µL PBS
and cells were stained using a HEMA 3 staining kit (Hema 3Manual Staining System, Fisher Diagnostics). The coverslips
were dried and mounted (Permount) for examination under a
100× oil immersion objective of a Zeiss Axioscope microscope.
Images were acquired using Axiovision 3.1 software (Carl Zeiss,
Thornwood, NY).
2.7. Statistical analysis
All analyses were performed using Prism 4 (San Diego, CA).
Multiple groups were compared by ANOVA and post hoc
analysis with Bonferroni Multiple Comparison test. Compar-
isons between the two groups were made using two-tailed t-test
and p valuesb0.05 were considered significant.
3. Results
3.1. Modification of the antibiotic exclusion assay
Incubation of B. dolosa AU4459 with a triple antibiotic
combination of 1 mg/mL of meropenem, ceftazidime and
amikacin for 3h resulted in the benchmark killing efficiency
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and for shorter time intervals did not (data not shown). Using
the same antibiotic combination over the same time interval,
100% killing efficiency was obtained for both B. cenocepacia
J2315 and PAO1. The possibility of antibiotic permeation into
the cells, and thus antimicrobial killing of internalized bacteria,
was explored through invasion studies of the sensitive strain of
PAO1 as it invaded into CFT1-LCFSN cells (3h incubation,
triple antibiotic combination). If significant concentrations of
the antibiotics accumulated in the cells allowing for intracellular
killing, we would see an apparent lack of invasion of PAO1 into
these cells. Instead, PAO1 invaded with efficiencies of 0.4% at
2h and 0.5% at 3h.
3.2. Microfilament and microtubular dependent invasion
To evaluate B. dolosa AU4459 invasion into respiratory
epithelial cells, and look for evidence of mf and mt involvement,
TEMs of CFT1-LCFSN (WT-CFTR) cells were obtained. TEMs
showed finger-like projections at the cell surface that aligned with
invading bacteria (Fig. 1A). Additional evidence for possible mt
involvement in the invasion process included the perinuclear
localization of bacteria-filled vacuoles (Fig. 1B).
Using a modified antibiotic exclusion assay, B. cenocepacia
invaded WT-CFTR expressing CFT1-LCFSN respiratory
epithelial cells with an efficiency of 0.05%. Inhibition of mf
and mt rearrangements significantly reduced the frequency of
entry into CFT1-LCFSN to 0.006% (mf, cytochalasin D) and
0.011% (mt, colchicine), or 88% and 78% reduction of the
control level, respectively (Fig. 2A). In comparison, B. dolosaFig. 2. Affect of microfilament and microtubular inhibition on B. cenocepacia and B
CFT1-LCFSN, WT-CFTR expressing cells incubated with either vehicle, the microt
(cytoD). B. Entry of B. dolosa into CFT1-LCFSN cells. C. Entry of B. cenocepacia in
Bacterial entry is significantly reduced (pb0.05) with microtubule and actin filameninvaded CFT1-LCFSN cells with 25% efficiency. Invasion
dropped to b0.5% after inhibition of either mf or mt, a 98%
reduction of the control level (Fig. 2B). Thus, both B. dolosa
and B. cenocepacia are dependent on these pathways for entry
into respiratory epithelial cells.
To determine if mt and mf invasion was cell line specific, the
assay was repeated inWT-CFTR expressing 16HBE cells and the
results mirrored those found with CFT1-LCFSN cells. B.
cenocepacia invaded with 0.03% efficiency, which decreased to
0.008% efficiency (73% decrease) when colchicine was added
(pb0.01), and 0.002% when cytochalasin D was added (93%
decrease; pb0.001) (Fig. 2C). B. dolosa invaded with 16%
efficiency, which decreased to 4.4% with colchicine (73%
decrease; pb0.01) and 1.7% with cytochalasin D (89% decrease;
pb0.001) (Fig. 2D).
The possibility of intracellular replication of bacteria during
the three hour antibiotic incubation step of the modified invasion
assay was explored. The standard gentamicin invasion assay used
with gentamicin sensitive bacteria involves a one hour incubation
step with the antibiotic to kill off extracellular bacteria. The B.
dolosa studied in our invasion assay, however, required a three
hour incubation with the triple antibiotic cocktail to obtain the
99.99% killing efficiency required for valid interpretation of the
invasion assay. We compared the efficiency of invasion
efficiency of B. dolosa and B. cenocepacia into CFT1-LCFSN
cells at the same MOI after incubation with the triple antibiotic
combination for either 2 or 3 h. The invasion frequencies between
the different time periods were comparable (B. dolosa invading at
16% efficiency at 2 h and 18% at 3 h, andB. cenocepacia invaded
at 0.2% at 2 h and 0.1% at 3 h), suggesting that intracellular. dolosa entry into respiratory epithelial cells. A. Entry of B. cenocepacia into
ubule inhibitor colchicine (colch) or the actin filament inhibitor cytochalasin D
to 16HBE, WT-CFTR expressing cells. D. Entry of B. dolosa into 16HBE cells.
t inhibition in all cell lines with both bacterial isolates.
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ascertain whether the bacteria caused cell death, apoptosis studies
were performed on the respiratory epithelial cells. No signifi-
cant apoptosis was noted with incubation with P. aeruginosa,
B. dolosa or B. cenocepacia over time periods up to 3 h with
varying MOIs (data not shown).
3.3. CFTR dependent invasion
To evaluate qualitative differences in invasion between the two
different respiratory epithelial cell types due to CFTR function,
TEMs of CFT1-LCFSN (WT-CFTR) and CFT1-LC3 (ΔF508-
CFTR) cells were obtained after incubation with B. dolosa
AU4459. Fewer finger-like projections were seen in CFT1-LC3
(ΔF508-CFTR) compared with CFT1-LCFSN (WT-CFTR)
cells (Fig. 3) suggesting that deficiency in CFTR altered the
ability of epithelial cells to respond to bacteria with cell uptake
mechanisms.
CFT1-LCFSN (WT-CFTR) and CFT1-LC3 (ΔF508-CFTR)
cells were used in invasion assays to quantitatively determine if
CFTR function affected invasion. Invasion ofB. cenocepacia intoFig. 3. Cell ultrastructural change induced by B. dolosa in the presence and absence
CFT1-LCFSN cells (A. and B.) and ΔF508-CFTR expressing CFT1-LC3 cells (C. a
LCFSN surface and aligning with entering bacterium, as compared to the sparse celthe WT-CFTR (CFT1-LCFSN) and the ΔF508-CFTR (CFT1-
LC3) cells were not different (0.05% and 0.07% respectively;
pN0.05; Fig. 4A). For B. dolosa, however, a statistically sig-
nificant difference was found between the invasion of the WT-
CFTR (CFT1-LCFSN) and the ΔF508-CFTR (CFT1-LC3)
respiratory epithelial cells (28% vs 5% respectively; pb0.001;
Fig. 4B). Thus, CFTR function appears to play a role inB. dolosa,
but not B. cenocepacia invasion.
3.4. Dependence of invasion efficiency on inoculum
Because bacterial invasion efficiency may depend on the
initial inoculum, invasion assays using WT-CFTR (CFT1-
LCFSN) respiratory epithelial cells exposed to a range of
different MOI values were performed. The invasion efficiency
of B. dolosa AU4459 increased to an MOI of approximately 35
and then declined, whereas invasion efficiency of B. cenoce-
pacia J2315 peaked at an MOI of approximately 60 and then
declined (Fig. 4C–D). Because CFTR expression had been
shown to affect B. dolosa invasion, we examined the MOI
variation of invasion efficiency using ΔF508-CFTR (CFT1-of functional CFTR. Entry of B. dolosa bacterium into WT-CFTR expressing
nd D.). Note the more numerous cellular projections emanating from the CFT1-
lular projections of the CFT1-LC3 cells. All scale bars=1 µm.
Fig. 4. B. dolosa invasion efficiency changes with MOI and CFTR expression. A. Entry of B. cenocepacia into CFT1-LCFSN (WT-CFTR) and CFT1-LC3 (ΔF508-
CFTR) cells (pN0.05). B. Entry of B. dolosa into CFT1-LCFSN and CFT1-LC3 cells (pb0.05). Per cent change in entry frequency of B. dolosa over differing MOIs
in C. CFT1-LCFSN (WT-CFTR) and D. CFT1-LC3 (ΔF508-CFTR) respiratory epithelial cells. The insert in panel D depicts the same information on an expanded
Y axis.
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ΔF508-CFTR cells was less than that of the WT-CFTR cells
at all MOIs studied.
3.5. Dependence of adherence on CFTR expression
To determine if there was a difference in bacterial adherence
to respiratory epithelial cells with or without a functioning
CFTR (WT-CFTR LCFSN or ΔF508-CFTR LC3 cells,
respectively), which could explain differences in bacterial
invasion between the two cell types, an adherence assay was
performed. Similar bacterial clumping occurred in both LCFSN
and LC3 cell types (Fig. 5A–D). A quantitative adherence assay
did not reveal differences between the two groups (unpaired t-
test, p=0.5075; Fig. 5E). Accordingly, the observed difference
in invasion efficiency of B. dolosa into WT- and ΔF508-CFTR
expressing cells does not appear to be due to differences in
adherence.
4. Discussion
Bacterial-host interactions have been studied extensively in
invasive gram negative enteric bacterial species and involve
mobilization of the target cell's cytoskeletal componentsleading ultimately to bacterial phagocytosis, invasion and
disease [9,18]. In comparison, bacterial-host interactions of
invasive respiratory pathogens have not been as well docu-
mented. In the CF lung, bacteria residing in the airway lumens
proliferate simultaneous with host attempts to clear them
through macrophage and epithelial uptake, neutrophil killing
and mucociliary clearance. In the case of P. aeruginosa,
epithelial cell uptake is followed by epithelial cell apoptosis and
clearance. Conversely, P. aeruginosa may also enter epithelial
cells to replicate, thus avoiding rapid removal by macrophage
phagocytosis or mucociliary clearance. P. aeruginosa has been
shown to engage microfilaments, microtubules and CFTR
protein in its interactions with respiratory epithelial cells [21].
Similarly, some Bcc members invade host epithelial cells
[2,4,16], and microtubule involvement has been demonstrated
for B. cenocepacia invasion [2]. A role for microfilaments in
Bcc invasion, however, has not been demonstrated and in
particular, invasion strategies of B. dolosa, especially the highly
successful and deadly epidemic strain SLC-6 [10], has not been
studied. Due to their close kinship, a parallel to the pathogenesis
of P. aeruginosa is probable. However, whether invasion of
respiratory epithelial cells leads to progression of infection, as
seen with enteric gram negative bacteria, or to accelerated
clearance from the respiratory track is yet to be determined.
Fig. 5. Similar adherence of B. dolosa to WT-CFTR and ΔF508-CFTR
expressing epithelial cells. CFT1-LCFSN (WT-CFTR, panels A. and B.) and
CFT1-LC3 cells (ΔF508-CFTR, panels C. and D.) stained with Giemsa in order
to visualize bacteria. Scale bar=10 µm. Cells shown in panels A. and C. are
uninfected; cells in panels B. and D. were incubated for 1 h with 105CFU of B.
dolosa prior to washing and staining. Arrowheads point to clumps of adherent
bacteria. Panel E. depicts the results of 3 separate quantitative adhesion assays
performed in triplicate. Data are presented as mean and standard deviation. No
statistical difference was found between the two groups (pN0.5).
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B. dolosa invade two different types of WT-CFTR expressing
respiratory epithelial cells (CFT1-LSFCN and 16HBE). Elec-
tron micrographs of B. dolosa interacting with CFT1-LCFSN
cells showed fingerlike projections from the plasma membrane
of the respiratory epithelial cell surrounding invading bacteria.
Once internalization occurred, bacteria were found in peri-
nuclear locations, which is associated with microtubular
trafficking [1]. These observations prompted invasion assays
that demonstrated both microtubule and microfilament involve-
ment in B. cenocepacia and B. dolosa invasion.
Further electron microscopic studies of B. dolosa AU4459
invading both WT- and ΔF508-CFTR expressing cells showed
many more fingerlike projections emanating from WT-CFTR
cells exposed to B. dolosa compared with ΔF508 cells,
suggesting that CFTR may be involved in invasion. WT-
CFTR expression dramatically enhanced the uptake of B.
dolosa, but not B. cenocepacia. It is possible that internalization
of B. dolosa by respiratory epithelial cells may represent an
important mechanism of bacterial clearance from the host witha functional CFTR. Patients with defective CFTR may not
internalize inhaled bacteria as rapidly as control subjects with
WT-CFTR. This time delay may allow the bacteria to replicate
or communicate via quorum sensing and begin formation of
biofilms. In support of this possibility, TEMs of B. dolosa
interacting with ΔF508-CFTR cells showed clusters of
extracellular bacteria in microcolonies that exhibited the
coccobacilli morphology typical of gram negative rods in
biofilms. These microcolonies were not seen in photomicro-
graphs of B. dolosa interacting with WT-CFTR cells (data not
shown).
The hypothesis that a functioning CFTR protein is required for
maximal bacterial entry of B. dolosa into respiratory epithelial
cells is further supported by the bacterial adherence andMOI data
generated on B. dolosa in ΔF508 and WT-CFTR expressing
cells. CFTR does not affect the capacity of the bacteria to adhere
to the surface of the respiratory epithelial cells. As the bacteria
number at the cell surface increases, the efficiency of invasion
increases until it peaks and then falls, indicating that the system is
saturable. B. dolosa reaches this saturation point around an MOI
of 35 in ΔF508-CFTR cells as compared to WT-CFTR cells at
an MOI of 60. Thus, B. dolosa invades WT-CFTR cells with
much higher efficiency than ΔF508-CFTR cells. B. dolosa may
bind directly to CFTR itself mirroring the WT-CFTR dependent
mechanisms of internalization of P. aeruginosa into respiratory
epithelial cells [3]. The decreased internalization efficiency in the
ΔF508-CFTR cells may reflect decreased receptor density at the
cell surface. We propose that mutated CFTR protein leads to less
internalization of B. dolosa, less clearance, and higher bacterial
burden outside of the cell allowing for accelerated biofilm forma-
tion. However, a functioning CFTR protein is not required for
all bacterial invasion sinceB. dolosa also invades theΔF508 LC3
respiratory epithelial cells. Furthermore, microfilament and
microtubule inhibition affects invasion efficiency in all cell
types regardless of CFTR functioning. In the case of P.
aeruginosa, internalization of the organism triggers apoptosis of
the cell [3] preventing spread of infection to neighboring cells. For
B. dolosa, TEMs showed similar evidence of cellular apoptosis in
invaded cells (data not shown) and staining of the infected
respiratory epithelial cells over one, two and three hour time
periods showed increasing numbers of cells undergoing apoptosis
(2–3% apoptosis at three hours). While the cellular apoptosis rate
does not significantly affect the invasion results over a three hour
time period, apoptosis in infected respiratory epithelial cells over
a longer time period (24 h) has been shown to be significant [3].
Further studies are needed to assess the role that CFTR and
cellular apoptosis may play in the pathogenesis of infection with
Bcc organisms. Also, more studies are warranted to determine the
mechanism through which CFTR protein interaction with
microfilaments and microtubules enhances B. dolosa invasion
efficiency into respiratory epithelial cells and the role that that
enhanced uptake may play in clearance of the organism.
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